Home » IPO reminder: Yahong Pharmaceutical, Sunway World subscribe today_ Securities Times

IPO reminder: Yahong Pharmaceutical, Sunway World subscribe today_ Securities Times

by admin
</p> <p> IPO reminder: Yahong Pharmaceutical, Sunway <a data-ail="269202" target="_blank" href="https://www.breakinglatest.news/category/world/" >World</a> subscribe today_ Securities Times<br />

Home> News> e Company

IPO reminder: Yahong Pharmaceutical, Sunway World apply for purchase today

2021-12-27 09:26

Source: Securities Times·e Company

Author: Kuaishou Xiaoe

Securities Times·e Company

Kuaishou Xiaoe

2021-12-27 09:26

Securities Times e company news, today can subscribe for Yahong Medicine and Sunway World. Yahong Pharma subscription code: 787176, subscription price: 22.98 yuan, single account subscription limit is 20,500 shares; Sanwei Tiandi issued a P/E ratio of 44.81 times, subscription code: 301159, subscription price: 30.28 yuan, single account subscription limit is 19,000 shares, subscription The number is an integer multiple of 500 shares. The main business of the company: IT system construction for institutional clients. (This manuscript was completed by the writing robot “Kaishou Xiaoe” of Securities Times e company.)

Statement: The Securities Times strives to be truthful and accurate. The content mentioned in the article is for reference only and does not constitute substantive investment advice. The operation is at your own risk accordingly.

  • Securities Times APP
  • WeChat public account


  • 4011803

    IPO reminder: Yahong Pharmaceutical, Sunway World apply for purchase today

    6885

    e company

    news

    1445

    Kuaishou Xiaoe

    2021-12-27

    See also  Labor market, ADP report: 475,000 new jobs created in the private sector in February, January numbers boom upgrade

    You may also like

    Leave a Comment

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

    Privacy & Cookies Policy